At Aflac, we try to live by this very simple rule: Everyone has the power to do good. We have unveiled Aflac’s 2016 Corporate Social Responsibility (CSR) Report, where we share with you how Aflac strives to be a good neighbor with good people leading the way - Learn more here. 

Moving beyond audit and shift mindsets across your supply chain and internally might be the hardest task but truly engaging suppliers in sustainability is key to reduce costs, drive efficiencies and minimise risk to ensure business impact, reputation and competitiveness. We brought together 3 senior leaders in this space to share their experiences and strategies, and to help you in measuring the bottom line benefits to prove the business case. Hear from:

• Compound has potential to be a game-changer in malaria elimination, rapidly clearing malaria infection, including resistant strains, and blocking parasite transmission

• KAF156 is first compound from the imidazolopiperazines, a novel class of antimalarials, to enter phase IIb combination studies

• Clinical trial has started early August in adults with malaria and is planned to expand to adolescents and children in a total of nine countries in Africa and Asia

The socially responsible investment sector is recording unprecedented growth since the Trump administration took office. Since January, Morningstar, a fund-tracking firm, has logged a four-times increase in the use of ESG data in its cloud platform, a base for research by asset managers, advisory firms, and independent wealth managers.